AQR Capital Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.81M | Buy |
157,805
+23,548
| +18% | +$1.02M | 0.01% | 1125 |
|
|
2025
Q1 | $4.64M | Sell |
134,257
-89,316
| -40% | -$3.09M | ﹤0.01% | 1158 |
|
|
2024
Q4 | $6.13M | Buy |
223,573
+27,610
| +14% | +$758K | 0.01% | 1013 |
|
|
2024
Q3 | $4.99M | Buy |
195,963
+70,803
| +57% | +$1.8M | 0.01% | 1062 |
|
|
2024
Q2 | $3.17M | Sell |
125,160
-4,800
| -4% | -$122K | ﹤0.01% | 1247 |
|
|
2024
Q1 | $4.02M | Buy |
129,960
+96,926
| +293% | +$3M | 0.01% | 1073 |
|
|
2023
Q4 | $1.33M | Buy |
33,034
+10,832
| +49% | +$437K | ﹤0.01% | 1499 |
|
|
2023
Q3 | $585K | Sell |
22,202
-3,622
| -14% | -$95.5K | ﹤0.01% | 1791 |
|
|
2023
Q2 | $444K | Buy |
+25,824
| New | +$444K | ﹤0.01% | 1825 |
|
|
2021
Q4 | – | Sell |
-15,685
| Closed | -$735K | – | 2200 |
|
|
2021
Q3 | $735K | Buy |
15,685
+7,917
| +102% | +$371K | ﹤0.01% | 1706 |
|
|
2021
Q2 | $474K | Sell |
7,768
-10,122
| -57% | -$618K | ﹤0.01% | 1917 |
|
|
2021
Q1 | $1.1M | Buy |
17,890
+13,989
| +359% | +$862K | ﹤0.01% | 1511 |
|
|
2020
Q4 | $277K | Sell |
3,901
-1,848
| -32% | -$131K | ﹤0.01% | 1995 |
|
|
2020
Q3 | $216K | Sell |
5,749
-40,976
| -88% | -$1.54M | ﹤0.01% | 2033 |
|
|
2020
Q2 | $1.52M | Buy |
+46,725
| New | +$1.52M | ﹤0.01% | 1284 |
|